Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 267

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 267
---
OLDERS’ DEFICIT (UNAUDITED)

| ​                                                                     
 ​                                                                     
 ​                                                                     
 ​                                                                     
 ​                                                                     | ​ 
 ​ 
 ​ 
 ​ |            ​ 
 Common Stock 
      Class A 
            ​ 
       Shares | ​ 
 ​ | ​      
 ​      
 Amount |   ​ 
   ​ | ​ 
 ​ 
 ​ 
 ​ | ​            
 Extension    
 deposits due 
 from         
 Sponsor      |        ​ | ​ 
 ​ 
 ​ 
 ​ | ​          
 ​          
 Additional 
 Paid-in    
 Capital    |       ​ 
       ​ | ​ 
 ​ 
 ​ 
 ​ | ​           
 ​           
 Accumulated 
 Deficit     |           ​ 
           ​ 
           ​ | ​ 
 ​ 
 ​ 
 ​ | ​             
 Total         
 Stockholders’ 
 Deficit       |           ​ 
           ​ |
|:----------------------------------------------------------------------|:--|-------------:|:--|:-------|----:|:--|:-------------|---------:|:--|:-----------|--------:|:--|:------------|------------:|:--|:--------------|------------:|
| Balance as of January 1, 2025                                         | ​ |    6,900,000 | ​ | $      | 690 | ​ | $            | -160,677 | ​ | $          |  51,795 | ​ | $           | -17,518,175 | ​ | $             | -17,626,367 |
| Deemed contribution for extension deposit from Sponsor                |   |            — |   | ​      |   — |   | ​            |  -31,406 |   | ​          |  31,406 |   | ​           |           — |   | ​             |           — |
| Remeasurement of Class A common stock to redemption amount            |   |            — |   | ​      |   — |   | ​            |        — |   | ​          | -37,585 |   | ​           |           — |   | ​             |     -37,585 |
| Excise tax payable attributable to redemption of Class A common stock |   |            — |   | ​      |   — |   | ​            |        — |   | ​          |       — |   | ​           |      -7,024 |   | ​             |      -7,024 |
| Net loss                                                              |   |            — |   | ​      |   — |   |